Laboratorio Reig Jofre SA Share Price Cinnober Boat
Stocks
0RB1
ES0165359029
Pharmaceuticals
| Market Cap | 217M 0 252M 202M 186M 349M 24.13B 355M 2.39B 934M 12.1B 948M 927M 40.01B | P/E 2026 * |
13.3x | P/E 2027 * | 22.2x |
|---|---|---|---|---|---|
| Enterprise Value | 301M 0 351M 281M 258M 485M 33.57B 493M 3.32B 1.3B 16.84B 1.32B 1.29B 55.66B | EV / Sales 2026 * |
0.83x | EV / Sales 2027 * | 0.75x |
| Free-Float |
20.57% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Laboratorio Reig Jofre SA
| 1 day | +2.41% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 31/12/2005 | |
Laura Martí
DFI | Director of Finance/CFO | - | 19/12/2023 |
Carmen Esclapés
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/12/2014 | |
| Director/Board Member | 58 | 30/12/2014 | |
| Director/Board Member | - | 06/11/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.41% | -.--% | - | - | 250M | |
| +4.46% | +5.38% | +83.42% | +134.31% | 1,093B | |
| +0.85% | +5.24% | +55.13% | +58.51% | 653B | |
| +2.72% | +6.35% | +28.76% | +77.15% | 458B | |
| +1.80% | -0.41% | +43.52% | +44.05% | 355B | |
| +1.24% | +1.00% | +26.84% | +42.21% | 294B | |
| +2.07% | +1.74% | +2.66% | +13.06% | 248B | |
| +4.02% | +6.77% | +51.17% | +68.96% | 230B | |
| +1.05% | -2.52% | -13.83% | -52.13% | 203B | |
| +2.90% | +8.71% | +25.10% | +94.52% | 178B | |
| Average | +1.97% | +1.20% | +33.64% | +53.40% | 412.27B | |
| Weighted average by Cap. | +1.53% | +1.45% | +47.89% | +73.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 365M 0 425M 341M 313M 588M 40.66B 598M 4.02B 1.57B 20.39B 1.6B 1.56B 67.42B | 392M 0 457M 366M 336M 631M 43.67B 642M 4.32B 1.69B 21.9B 1.72B 1.68B 72.41B |
| Net income | 16.7M 0 19.47M 15.59M 14.31M 26.9M 1.86B 27.35M 184M 72.05M 933M 73.1M 71.51M 3.09B | 9.5M 0 11.07M 8.87M 8.14M 15.3M 1.06B 15.56M 105M 40.99M 531M 41.58M 40.68M 1.76B |
| Net Debt | 84.7M 0 98.74M 79.09M 72.56M 136M 9.44B 139M 933M 365M 4.73B 371M 363M 15.65B | 78.7M 0 91.75M 73.49M 67.42M 127M 8.77B 129M 867M 340M 4.4B 344M 337M 14.54B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
